EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.1 USD | -0.07% |
|
+3.06% | +18.16% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 54 M€ | +1.52% | - | |
| 0.01% | 112 M€ | +5.51% | - | |
| 0.01% | 169 M€ | +0.64% | - | |
| 0.01% | 34 M€ | +4.26% | - | |
| 5.02% | 129 M€ | +8.06% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
25/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.11
USD
Average target price
95.9
USD
Spread / Average Target
+6.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.16% | 54.3B | |
| +12.50% | 228B | |
| +14.52% | 196B | |
| +17.51% | 141B | |
| +28.96% | 110B | |
| +3.27% | 65.88B | |
| +7.63% | 52.39B | |
| +10.95% | 45.22B | |
| +5.10% | 37.12B | |
| +27.85% | 32.32B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
